Skip to main content
HairCited

Vitamin D für Weiblicher Haarausfall

A

Basierend auf 18 Studien (2 meta-analyses) mit 15,494 Teilnehmern insgesamt. Die Ergebnisse sind uneinheitlich zwischen den Studien.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Fazit

Research shows that women with pattern hair loss often have lower vitamin D levels, but supplementing with vitamin D alone is unlikely to significantly improve this condition — it may be one supportive factor among many.

  • Lower vitamin D levels are consistently found in women with pattern hair loss
  • Supplementation alone is less effective than established options like minoxidil
  • Vitamin D receptor gene variants may influence susceptibility
  • Maintaining adequate vitamin D may support overall hair health but is not a standalone solution

Key Study Findings

narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs.: Placebo Wirkung: None None
Meta-analysis
Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis.
Dose: None vs.: Placebo Wirkung: OR=2.84 (AA vs controls), OR=5.24 (FPHL vs controls) p<0.01
cross-sectional observational n=120
Filling the Gaps: Vitamin D Status in Diffuse Hair Fall Among Pakistanis.
Dose: None vs.: Placebo Wirkung: 79.17% of patients with diffuse hair fall were vitamin D3 deficient (mean 17.33 ± 5.43 ng/mL) None
meta_analysis n=10670
Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis.
Dose: not applicable (observational meta-analysis) vs.: Placebo Wirkung: WMD -7.29 ng/mL (95% CI -9.21, -5.38); OR for vitamin D deficiency 3.11 (95% CI 2.29, 4.22) not explicitly stated; CI does
Case-control n=165
The development of non-scarring alopecia in women who wear the hijab.
Dose: None vs.: Placebo Wirkung: OR=4.1 (95% CI 1.2-14.1) for vitamin D deficiency and telogen effluvium p=0.02
Other
Serum ferritin and vitamin D levels in women with non-scarring alopecia.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: Women with non-scarring alopecia

Key Statistics

19

Studien

15494

Teilnehmer

Mixed

A

Bewertung

Referenced Papers

Archives of dermatological … 2023 3 Zitierungen
Journal of cosmetic … 2021 44 Zitierungen
International journal of … 2020 18 Zitierungen
Experimental dermatology 2017 82 Zitierungen
International journal of … 2017 61 Zitierungen
International journal of … 2016 42 Zitierungen
International journal of … 2016 28 Zitierungen
Skin pharmacology and … 2013 127 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
600-800 IU/day
deficiency:
1,000-5,000 IU/day

Obergrenze: 4,000 IU/day

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Positive --
None -- Negative --
None -- Neutral 120
not applicable (observational meta-analysis) -- Negative 10670
None -- Positive 165
None -- Mixed --
None -- Negative --
1000 IU vitamin D3 daily 16 weeks Positive 2

Beste Einnahmezeit: With a fat-containing meal for optimal absorption

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

Bekannte Wechselwirkungen

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)

Tolerierbare Höchstaufnahmemenge: 4,000 IU/day

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Vitamin D help with Weiblicher Haarausfall?
Based on 19 studies with 15,494 participants, there is strong evidence from multiple clinical trials that Vitamin D may support Weiblicher Haarausfall management. Our evidence grade is A (Strong Evidence).
How much Vitamin D should I take for Weiblicher Haarausfall?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Weiblicher Haarausfall?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 19 peer-reviewed studies with 15,494 total participants. The overall direction of effect is mixed.

Related Evidence

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.